Celltrion, “Biogen’s confirmation trials are only a part of procedures for the Patent Linkage System”

When it comes to the 3 active confirmation trials for the scope of the right, which was filed by Biogen over CT-P10(product name: Truxima) against Celltrion, Celltrion expressed opinions.

On the 15^th, Celltrion stated the confirmation trials filed by the original company, Biogen, on the 4^th of February was a procedure for the Patent Linkage System and has no chance to be excessively interprete...